コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 of nitric oxide metabolites (ie, nitrite and nitrosothiols).
2 ion that converts a protein Cys thiol to a S-nitrosothiol.
3 m exposure to free *NO but not from cellular nitrosothiol.
4 intracellular reactive oxygen species and S-nitrosothiol.
5 ependent conformational change, to form an S-nitrosothiol.
6 logical response to this biologically active nitrosothiol.
7 th a second NO molecule to produce HNO and a nitrosothiol.
8 teine thiol (or thiolate anion) to form an S-nitrosothiol.
9 form thionitrous acid (HSNO), the smallest S-nitrosothiol.
10 ite versus chemical intermediates, such as S-nitrosothiols.
11 s encompassing the cellular homeostasis of S-nitrosothiols.
12 s release occurs due to NO liberation from S-nitrosothiols.
13 erate high levels of intracellular protein S-nitrosothiols.
14 al effects of nitric oxide are mediated by S-nitrosothiols.
15 be involved in the regulation of cellular S-nitrosothiols.
16 cellular activity of small molecular weight nitrosothiols.
17 es and the instability of cellular protein S-nitrosothiols.
18 beta subunit (cysbeta-93) to form bioactive nitrosothiols.
19 ult in decreased rates of decomposition of S-nitrosothiols.
20 intracellular glutathione and formation of S-nitrosothiols.
21 and the subsequent formation of NO-donating nitrosothiols.
22 that NO reacts with ---SH groups, forming S-nitrosothiols.
23 species and related modifications such as S-nitrosothiols.
24 anion, the nitric oxide free radical, and S-nitrosothiols.
25 of enzymatic control of cellular thiols and nitrosothiols.
26 from reaction of copper(II) thiolates with S-nitrosothiols.
27 ducts, with a decrease in the formation of S-nitrosothiols.
28 e presence of nitrite to form N(2)O(3) and S-nitrosothiols.
29 can be achieved through rational design of S-nitrosothiols.
30 gnificantly higher concentrations of total S-nitrosothiols (11.1+/-2.9 nmol/mL) than normal pregnancy
32 ation, did not change total red blood cell S-nitrosothiol abundance but did shift S-nitrosothiol dist
33 manually curated data set of proteins with S-nitrosothiols, accounting for a variety of biochemical f
34 ion of NO provides the fully characterized S-nitrosothiol adduct [Cu(I)](kappa(1)-N(O)SR), which reve
39 Further reaction of HNO with the remaining S-nitrosothiol and thiol results in the generation of othe
40 this is a NO-containing factor such as an S-nitrosothiol and/or a dinitrosyl-iron (II) cysteine comp
43 f apparent total N-nitroso compounds (ATNC), nitrosothiols and nitrosyl iron compounds (FeNO) were an
48 could facilitate nitric oxide release from S-nitrosothiols and represents a potential physiological m
50 hrough exposure to cell membrane-permeable S-nitrosothiols and that sGC is S-nitrosylated and desensi
51 r ascorbate leads to the generation of NO or nitrosothiols and thus stimulates the activation of sGC.
53 to stain for NADPH diaphorase were rich in S-nitrosothiols, and (7) procedures that accelerate decomp
55 to the anaerobic regulon protected against S-nitrosothiols, and anaerobic growth of E. coli lacking O
56 acellular-reduced glutathione (GSH), protein nitrosothiols, and the activation of the transcription f
57 erin (GTN) and nitric oxide donors such as S-nitrosothiols are clinically vasoactive through stimulat
64 ndicates that hypoxic vasodilation entails S-nitrosothiol-based (SNO-based) vasoactivity (rather than
65 exploited in the evolutionary development of nitrosothiol-based innate immunity and may provide an av
68 cus is on oxidized nitrogen in the form of S-nitrosothiol bond-containing species, which are now appr
69 d was evaluated as a fluorescence probe of S-nitrosothiol-bound NO transfer in human umbilical vein e
70 irst gel-based method to identify not only S-nitrosothiols but also other labile NO-based modificatio
71 y of ascorbate to generate a thiol from an S-nitrosothiol, but not from alternatively S-oxidized thio
73 Findings indicate that nitrate, nitrite and nitrosothiols, but not NO or iron nitrosyl species (FeNO
76 howed that exposure to nitric oxide and to S-nitrosothiols causes S-nitrosylation of sGC, which direc
77 m accounts for several unexplained facets of nitrosothiol chemistry in solution, including the observ
80 e conclude that S-nitrosoalbumin and total S-nitrosothiol concentrations are significantly increased
83 Compared to similar measurements of total S-nitrosothiol content in bulk solution, use of the microf
84 ys a key role in cellular redox homeostasis, nitrosothiol content in cells, and antiapoptotic signali
85 1+/-25 pmol/mg protein, respectively) when S-nitrosothiol content was expressed per milligram protein
86 lcysteine (SNOAC), decreasing erythrocytic S-nitrosothiol content, both during whole-blood deoxygenat
88 IPC and GSNO both significantly increased S-nitrosothiol contents and S-nitrosylation levels of the
89 atment with NO donors (increasing cellular S-nitrosothiol contents) substantially enhanced the initia
93 RT externalization occurred together in an S-nitrosothiol-dependent and caspase-independent manner.
95 enitrosylated RBCs than during infusion of S-nitrosothiol-depleted RBCs, and this difference in coron
97 alpha-NADP did not produce diformazan, (5) S-nitrosothiols did not promote NADPH-dependent reduction
98 ell S-nitrosothiol abundance but did shift S-nitrosothiol distribution to lower molecular weight spec
99 within endothelial cells from an exogenous S-nitrosothiol donor or from endogenous production of NO b
100 human monocytes as a model, we observed that nitrosothiol donors S-nitrosoglutathione and S-nitroso-N
101 onse in proportion to the concentration of S-nitrosothiols (e.g., nitrosocysteine, nitrosoglutathione
102 siological levels of nitric oxide (NO) and S-nitrosothiols (e.g., S-nitrosoglutathione, GSNO) and ari
104 sine monophosphate (cGMP) generation after S-nitrosothiol exposure (65.4 +/- 26.7% reduction compared
105 thiols modified using nitric oxide, termed S-nitrosothiols, facilitate the hypersensitive response in
107 nvolved both S- and N-nitrosation, and RBC S-nitrosothiol formation emerged as a sensitive indicator
108 r, is much less effective at intracellular S-nitrosothiol formation in the presence of L-cystine or L
110 desensitization and find that heme-assisted nitrosothiol formation of beta1Cys-78 and beta1Cys-122 c
112 ver, a subsequent incubation of the cells in nitrosothiol-free medium resulted in reconstitution of t
114 lytic Cu(II)/(I)-mediated decomposition of S-nitrosothiols generates NO(g) in the thin polymeric film
115 or microsome-associated thiols led to NO or nitrosothiol generation and thus stimulated the activati
117 ors (including a.NO donor [DeaNonoate], an S-nitrosothiol [GSNO], and the nitroxyl anion donor, Angel
119 tanding the biosynthesis and catabolism of S-nitrosothiols has proven to be difficult, in part becaus
122 rofluidic sensor to facilitate photolysis of nitrosothiols (i.e., S-nitrosoglutathione, S-nitrosocyst
124 ) enhanced the therapeutic actions of oral S-nitrosothiols in mouse models of C. difficile infection.
125 trol samples and 53.7% and 56.8% of plasma S-nitrosothiols in normal pregnancy and preeclampsia, resp
126 but not SNP or SIN-1, increased levels of S-nitrosothiols in SN56 proteins, consistent with the tran
127 n fraction contained 49.4% of total plasma S-nitrosothiols in the control samples and 53.7% and 56.8%
132 approximately 50% reduction in perfusate [S-nitrosothiol], in association with an increase in perfus
133 couple NAD(P)H oxidation with reduction of S-nitrosothiols, including protein and low-molecular-weigh
134 of dynamin2 or treatment with the NO donor S-nitrosothiols increases, whereas targeted reduction of e
135 nstituted domain peptides demonstrate that S-nitrosothiols indeed release zinc from both the alpha- a
137 lts suggest that inactivation of papain by S-nitrosothiols is due to a direct attack of the highly re
138 tudy, we demonstrate that the transport of S-nitrosothiols is essential for these compounds to affect
139 ay responsible for the cellular effects of S-nitrosothiols is specific for S-nitrosocysteine (CSNO),
140 Thionitrous acid (HSNO), the smallest S-nitrosothiol, is emerging as a potential key intermediat
141 se to exposure to both free nitric oxide and nitrosothiols (k (inact)/K(I) >= 5 m(-1) s(-1)), which i
142 whereas the BJR responses elicited by the S-nitrosothiol, L-S-nitrosocysteine (5 micromol/kg, i.v.),
144 thiol uptake, increasing the intracellular S-nitrosothiol level from approximately 60 pmol/mg of prot
146 uction of NO was paralleled by a decrease in nitrosothiol levels for 2 hour, suggesting that immediat
147 lysis, this device was used to measure basal nitrosothiol levels from the vasculature of a healthy po
149 ne biosynthesis pathway and an increase in S-nitrosothiol levels suggest S-nitrosylation to be a cons
150 estored intracardiac nitrite and increased S-nitrosothiol levels, decreased pathological cardiac mito
151 was accompanied by an increase in cellular S-nitrosothiol levels, modification of cysteines residues,
156 rocedures that accelerate decomposition of S-nitrosothiols, markedly reduced NADPH diaphorase stainin
157 cordingly, mutation of Cys 890 compromised S-nitrosothiol-mediated control of AtRBOHD activity, pertu
161 the catalytic site and that nitric oxide (or nitrosothiols) might act as a negative regulator of V-AT
163 cubated with cysteine, suggesting that these nitrosothiols must react with cysteine to form CSNO, whi
164 bioactivation, nitrite was reduced to NO, S-nitrosothiols, N-nitros-amines, and iron-nitrosylated he
165 one marrow-derived CD31(+)/CD45(-), plasma S-nitrosothiols, nitrite, and skeletal tissue cGMP levels
166 isulfide acts as a source of nitrosonium for nitrosothiol nitrosation, completing the catalytic cycle
167 ulated by redox reactions involving NO and S-nitrosothiols (nitrosative stress), emphasizing a versat
168 mass spectrometry, we found that NO forms S-nitrosothiols on Cys67 and Cys95 of HIV-PR which directl
169 d method for analyzing protein and peptide S-nitrosothiols on gels using the fluorescent probes 4,5-d
170 of NBT after modification, (2) addition of S-nitrosothiols or beta- or alpha-NADPH to solutions of NB
171 gical event when NO-dependent formation of S-nitrosothiols or peroxynitrite structurally modifies com
173 e data demonstrate for the first time that S-nitrosothiols oxidatively modify PTEN, leading to revers
177 ripheral circulation, and (iii) SNO-Hb and S-nitrosothiols play a minimal role in the regulation of b
178 l concentrations of nitrite and deoxyHb, a S-nitrosothiol precursor is formed within seconds and prod
179 onic chain mechanism in which nitrosation of nitrosothiol produces a nitrosated cation that, in turn,
180 Here we demonstrate that sulfinic acids and nitrosothiols react to form a stable thiosulfonate bond,
181 emical mechanism by which nitric oxide and S-nitrosothiols react with cysteine residues in ornithine
183 m normal placentas, and that NO, nitrite and nitrosothiols react with placental homogenates to form i
184 vivo Using this approach, called SNOxICAT (S-nitrosothiol redox isotope-coded affinity tag), we found
186 N) that leads to S-nitrosation to give the S-nitrosothiol RSNO and copper(II) hydroxide [Cu(II)]-OH.
187 study, we examined the chemical pathways of nitrosothiol (RSNO) production at low micromolar concent
188 itric oxide (NO) delivery is achieved from S-nitrosothiol (RSNO) type NO donor doped silicone rubber
190 oxidation leads to formation of vasoactive S-nitrosothiols (RSNO) in vitro and in vivo as detected el
202 with the low molecular mass cell-permeable S-nitrosothiol S-nitrosocysteine ethyl ester (SNCEE).
204 ein S-nitrosylation, the colocalization of S-nitrosothiol (S-NO) and protein-tyrosine phosphatase 1B
205 ing protein and low-molecular-weight (LMW) S-nitrosothiols (S-nitroso-GSH (GSNO) and S-nitroso-CoA (S
206 the specific transport of amino acid-based S-nitrosothiols (S-nitroso-L-cysteine and S-nitrosohomocys
207 /K(I) analyses, we quantified the ability of nitrosothiols (S-nitrosoglutathione and S-nitroso-N-acet
208 ries of novel diclofenac esters containing a nitrosothiol (-S-NO) moiety as a NO donor functionality
211 te activation and is the precursor of NO and nitrosothiols, serving as the link between organic nitra
212 ransformation and is the precursor of NO and nitrosothiols, serving as the link between organic nitra
213 te that zinc thiolate bonds are targets of S-nitrosothiol signaling and further indicate that MT-III
214 b) on HPV, expired NO (eNO), and perfusate S-nitrosothiol (SNO) concentration in isolated, perfused r
215 idney injury (AKI), double knockout (-/-), S-nitrosothiol (SNO) condition at a nitrosylation level of
220 Here we utilize antibodies specific for the nitrosothiol (SNO) moiety to provide an immunohistochemi
222 zinc finger transcription factor (ZF-TF), S-nitrosothiol (SNO) Regulated 1 (SRG1), is a central targ
223 in human erythrocytes haemoglobin-derived S-nitrosothiol (SNO), generated from imported NO, is assoc
224 etaCys93) that has been assigned a role in S-nitrosothiol (SNO)-based hypoxic vasodilation by RBCs.
226 ic vasodilation is recapitulated by native S-nitrosothiol (SNO)-replete RBCs and by SNO-Hb itself, wh
231 10(-4) at 3 h vs. 6.5 x 10(-4) (fresh) mol S-nitrosothiol (SNO)/mol Hb tetramer (P = 0.032, mercuric-
232 ed 1,276 S-nitrosylated cysteine residues [S-nitrosothiol (SNO)] on 491 proteins in resting hearts fr
234 mical reaction products [nitrite, nitrate, S-nitrosothiols (SNO), and nitrotyrosine] before, immediat
236 n (iron nitrosyl, FeNO) to cysteine thiol (S-nitrosothiol, SNO) that subserves bioactivation, and in
237 a family of NO-related molecules and that S-nitrosothiols (SNOs) are central to signal transduction
239 ereas treatments favoring stabilization of S-nitrosothiols (SNOs) decreased its cytotoxic potency.
240 e that nitric oxide (NO) and/or endogenous S-nitrosothiols (SNOs) exert protective effects in a varie
241 emical data demonstrate a pivotal role for S-nitrosothiols (SNOs) in mediating the actions of nitric
242 lation reflects dynamic equilibria between S-nitrosothiols (SNOs) in proteins and small molecules (lo
243 ly through protein S-nitrosylation to form S-nitrosothiols (SNOs) in target proteins, operates coordi
245 rd nitric oxide (NO) leads to formation of S-nitrosothiols (SNOs) that play important roles in pathog
247 dified the biotin switch assay for protein S-nitrosothiols (SNOs), using resin-assisted capture (SNO-
248 NO bioactivity is packaged in the form of S-nitrosothiols (SNOs), which are relatively resistant to
249 synthase (NOS), superoxide dismutase, and S-nitrosothiols (SNOs), which have recently been identifie
257 source of this NO is the already available S-nitrosothiol store rather than de novo synthesis by NOS.
258 through intracellular NO by modulation of S-nitrosothiol stores and stimulation of NOS activity.
259 nction as a generator for the formation of S-nitrosothiols such as S-nitrosoglutathione and, as such,
261 to cause vasodilation as compared to other S-nitrosothiols suggests potential application in biologic
262 data provide evidence for a physiological S-nitrosothiol synthase activity of tetrameric Hb that dep
265 thiols was used to explore the kinetics of S-nitrosothiol/thiol transnitrosation and was evaluated as
267 d cation that, in turn, reacts with a second nitrosothiol to produce nitrosated disulfide and the NO
268 in the enzyme active site on the sulfur of S-nitrosothiols to form a mixed disulfide between the inac
269 Here, we report that H(2)S reacts with S-nitrosothiols to form thionitrous acid (HSNO), the small
270 luded ultraviolet-induced decomposition of S-nitrosothiols to liberate NO captured by a florigenic re
271 did not elicit diformazan, (3) addition of S-nitrosothiols to solutions of NBT plus beta- or alpha-NA
272 sence of paraformaldehyde, (4) addition of S-nitrosothiols to solutions of NBT plus beta- or alpha-NA
273 This reaction converts unstable primary S-nitrosothiols to stable disulfide-iminophosphorane produ
274 mational changes in the toxin enabled host S-nitrosothiols to transnitrosylate the toxin catalytic cy
276 to be incompatible with life were all the S-nitrosothiols transformed into bioactive equivalents dur
277 this study, we have examined the effect of S-nitrosothiol transport on intracellular thiol status and
279 sence of L-cystine enhanced GSNO-dependent S-nitrosothiol uptake, increasing the intracellular S-nitr
284 ed by yeast flavohemoglobin against NO and S-nitrosothiols was seen under both anaerobic and aerobic
285 In addition, one of the dansyl-labeled S-nitrosothiols was used to explore the kinetics of S-nitr
286 kground nitrite and stabilizes erythrocyte S-nitrosothiols, we find the levels of SNO-Hb in the basal
287 nitrate, nitrite, and low-molecular-weight S-nitrosothiol were in the normal range; however, enhanced
293 ficantly more reactive than MT-I/II toward S-nitrosothiols, whereas the reactivity of all three isofo
294 lium induces a precipitous decline in cell S-nitrosothiol, which depends upon enhanced Trx activity a
295 is reflected in the level of intracellular S-nitrosothiols, which are constitutively metabolized.
296 wed by reductive generation of thiols from S-nitrosothiols, which are then labeled with either a biot
298 and thiols, furnishing iron nitrosyls and S-nitrosothiols with wide-ranging stabilities and reactivi
299 nges that occur after exposure of cells to S-nitrosothiol, with respect to thiol chemistry, are disti
300 g reactive cysteines, we hypothesized that S-nitrosothiols would oxidize PTEN and inhibit its phospha